Chinese Journal of Integrative Medicine

, Volume 21, Issue 4, pp 291–298 | Cite as

Inhibition mechanism of Qingluo Tongbi Granule (清络通痹颗粒) on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats

  • Tian-yang Liu (刘天阳)
  • Ling-ling Zhou (周玲玲)Email author
  • Cong Zhou (周 聪)
  • Zhang-pu Liu (柳璋璞)
  • Chen Chen (陈 晨)
  • Zhe Feng (冯 哲)
  • Xue-ping Zhou (周学平)Email author
Original Article



To study the mechanism underlying the inhibitory effect of Qingluo Tongbi Granule (清络通痹颗粒, QTG) on osteoclast differentiation in rheumatoid arthritis in rats.


Fibroblast and monocyte co-culture were used to induce osteoclast differentiation in adjuvant-induced arthritic (AIA) rats. Serum containing QTG was prepared and added to the osteoclasts, and activation of the tumor necrosis factor receptor-associated factor 6/mitogen-activated protein kinase/nuclear factor of activated T cells, cytoplasmic1 (TRAF6/MAPK/NFATc1) pathways was examined.


The induced osteoclasts were multinucleated and stained positive for tartrate-resistant acid phosphatase (TRAP) staining. Serum containing QTG at 14.4, 7.2 or 3.6 g/kg inhibited the activation of TRAF6, extracellular regulated protein kinase (ERK)1/2, c-Jun N-terminal kinase (JNK) and p38 and decreased the percentage of cells with nuclear NFATc1 in a dose-dependent manner, the high and middle doses exhibited clear inhibitory activity (P<0.01 and P<0.05, respectively). After the addition of MAPK inhibitors, the NFATc1 expression showed no significant difference compared with the control group (P>0.05).


Serum containing QTG could generally inhibit the TRAF6/MAPK pathways and possibly inhibit the NFATc1 pathway. In addition, QTG may regulate other signaling pathways that are related to osteoclast differentiation and maturation.


Qingluo Tongbi Granule rheumatoid arthritis osteoclast differentiation signaling pathway regulation of tumor necrosis factor receptor-associated factor 6/mitogen-activated protein kinase pathways Chinese medicine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dong Y. Rheumatoid arthritis. In: Ye RG, Zhong NS, eds. Internal medicine. Beijing: People’s Medical Publishing House; 2008:712–718.Google Scholar
  2. 2.
    Lu CJ, Xiang Y, Xie XL, Xuan ML, He ZH. A randomized controlled single-blind clinical trial on 84 outpatients with psoriasis vulgaris by auricular therapy combined with optimized Yinxieling Formula. Chin J Integr Med 2012;18:186–191.CrossRefPubMedGoogle Scholar
  3. 3.
    Liu C, Walter, TSH P, Zhang S, Zhu X, Wu Y, et al. Structural and functional insights of RANKL-RANK interaction and signaling. J Immunol 2010;184:6910–6919.CrossRefPubMedGoogle Scholar
  4. 4.
    Park MK, Her YM, Cho ML, Oh HJ, Park EM, Kwok SK. IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis. Immunol Lett 2011;139:42–51.CrossRefPubMedGoogle Scholar
  5. 5.
    Trouvin AP, Goëb V. Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. Clin Interv Aging 2011;19:345–354.Google Scholar
  6. 6.
    Yavropoulou MP, Yovos JG. Osteoclastogenesis—current knowledge and future perspectives. J Musculoskelet Neuronal Interact 2008;8:204–216.PubMedGoogle Scholar
  7. 7.
    Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y. Tumor necrosis factor-alpha (TNFα) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. Biol Chem 2001;276:563–568.CrossRefGoogle Scholar
  8. 8.
    Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, et al. Osteoclast differentiation independent of the TRANCERANK-TRAF6 axis. Exp Med 2005;202:589–595.CrossRefGoogle Scholar
  9. 9.
    Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002;3:889–901.CrossRefPubMedGoogle Scholar
  10. 10.
    Boyce BF, Yao Z, Xing L. Functions of nuclear factor kappa B in bone. Ann N Y Acad Sci 2009;1192:367–375.CrossRefGoogle Scholar
  11. 11.
    Xing L, Xiu Y, Boyce BF. Osteoclast fusion and regulation by RANKL-dependent and independent factors. World J Orthop 2012;12:212–222.CrossRefGoogle Scholar
  12. 12.
    Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA. The human osteoclast precursor circulates in the monocyte fraction. Endocrionlogy 1996;137:4058–4060.Google Scholar
  13. 13.
    Chen BS, Xu YD, Zhong SQ. Establishment and evaluation of experimental animal model of CFA induced adjuvant arthritis in rats. J Harbin Med Univ (Chin) 2009;39:489–491.Google Scholar
  14. 14.
    Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood monnuclear cell cultures. Biochem Biophy Res Commun 1998;246:199–204.CrossRefGoogle Scholar
  15. 15.
    Taira H, Fujikawa Y, Kudo O, Itonaga I, Torisu T. Menatetrenone (vitamin K2) acts directly on circulating human osteoclast precursors. Calcif Tissue Int 2003;73:78–85.CrossRefPubMedGoogle Scholar
  16. 16.
    Huang Y, Zhou XP, Wang MY, Zhou LL, Yang YH, Shen JR, et al. Effects of Qingluo Tongbi Granule on proliferation of fibroblast-like synoviocytes and RANKL expression in rheumatoid arthritis patients. Tradit Chin Drug Res Clin Pharmacol (Chin) 2009;20:510–512.Google Scholar
  17. 17.
    Zhou XP, Zhou LL, Jia M, Wang MY, Lu Y. Effects of Qingluo Tongbi Granule on RANKLE expression in T lymphocytes from RA patients. Chin J Immunol (Chin) 2008;24:1088–1099.Google Scholar
  18. 18.
    Zhou XP, Zhou LL, Song YH. The effects of Qingluo Tongbi Granule on the levels of cytokines in adjuvant induced arthritis rats. Chin J Immunol (Chin) 2003;19:545–547.Google Scholar
  19. 19.
    Zhou XP, Zhou LL, Liang W, Wang MY, Jiang HY, Fang TH. Effects of Qingluo Tongbi Granule on T lymphocyte subsets and TNF-α together IL-1 in synoviocytes of collagen induced arthritis in rats. Chin J New Drug Clin Remed (Chin) 2006;25:492–496.Google Scholar
  20. 20.
    Zhou XP, Fang TH, Zhou LL, Wang MY, Song YH, Xu DQ. Research of the molecular mechanisms of Qingluotongbi granule on rheumatoid arthritis. Pharmacol Clin Chin Mater Med (Chin) 2003;1:35–37.CrossRefGoogle Scholar
  21. 21.
    Han Y, Wang YP, Zhou LL. Effect of Qingluo Tongbi Granules on bone destruction in rats with adjuvant-induced arthritis (AIA). China Pharm (Chin) 2007;36:814–816.Google Scholar
  22. 22.
    Chen CH, Fang TH, Zhou LL, Zhou XP. Effect of Qingluo Tongbi Granule-containing serum on osteoblasts and osteoclast. Chin Tradit Patent Med (Chin) 2008;30:35–38.Google Scholar
  23. 23.
    Zhou XP, Liang W, Zhou LL, Wang MY, Liang T. The effects of Qingluo Tongbi Granule on the expression of p53 and bcl-2 mRNA in synoviocyte of collagen induced arthritis rats. Chin J Immunol (Chin) 2006;22:718–720.Google Scholar
  24. 24.
    Feng ZH. Cell communication and signal transduction. In: Feng HZ, ed. Medical molecular biology. Beijing: People’s Medical Publishing House; 2007:296–298.Google Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Tian-yang Liu (刘天阳)
    • 1
    • 2
  • Ling-ling Zhou (周玲玲)
    • 1
    Email author
  • Cong Zhou (周 聪)
    • 1
  • Zhang-pu Liu (柳璋璞)
    • 1
  • Chen Chen (陈 晨)
    • 1
  • Zhe Feng (冯 哲)
    • 1
  • Xue-ping Zhou (周学平)
    • 1
    Email author
  1. 1.Nanjing University of Chinese MedicineNanjingChina
  2. 2.Department of Rheumatology and ImmunologyThe First Affiliated Hospital of Anhui University of Chinese MedicineHefeiChina

Personalised recommendations